News Daily News Even With Optimized GDMT, HFrEF Prognosis Remains Dire Michael O'Riordan January 30, 2026
News Daily News Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors Yael L. Maxwell August 15, 2024
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Daily News LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD Michael O'Riordan July 11, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Daily News ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study Michael O'Riordan July 27, 2021
News Daily News Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms Michael O'Riordan April 02, 2021
News Conference News ESC 2020 COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020 Michael O'Riordan September 04, 2020
News Daily News Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data Michael O'Riordan July 14, 2020
News Daily News New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals Michael O'Riordan March 20, 2020
News Conference News ESC 2018 Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD Todd Neale August 31, 2018
News Conference News EAS 2018 Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention Yael L. Maxwell May 07, 2018
News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Daily News Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge Michael O'Riordan September 30, 2016
News Conference News ESC 2016 ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH Michael O'Riordan August 28, 2016